title: Dipicrylamine Modulates GABAρ1 Receptors through Interactions with Residues in the TM4 and Cys-Loop Domains.
abstract: Dipicrylamine (DPA) is a commonly used acceptor agent in Förster resonance energy transfer experiments that allows the study of high-frequency neuronal activity in the optical monitoring of voltage in living cells. However, DPA potently antagonizes GABAA receptors that contain α1 and β2 subunits by a mechanism which is not clearly understood. In this work, we aimed to determine whether DPA modulation is a general phenomenon of Cys-loop ligand-gated ion channels (LGICs), and whether this modulation depends on particular amino acid residues. For this, we studied the effects of DPA on human homomeric GABAρ1, α7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes. Our results indicate that DPA is an allosteric modulator of GABAρ1 receptors with an IC50 of 1.6 µM, an enhancer of α7 nicotinic receptors at relatively high concentrations of DPA, and has little, if any, effect on 5-HT3A receptors. DPA antagonism of GABAρ1 was strongly enhanced by preincubation, was slightly voltage-dependent, and its washout was accelerated by bovine serum albumin. These results indicate that DPA modulation is not a general phenomenon of LGICs, and structural differences between receptors may account for disparities in DPA effects. In silico modeling of DPA docking to GABAρ1, α7 nicotinic, and 5-HT3A receptors suggests that a hydrophobic pocket within the Cys-loop and the M4 segment in GABAρ1, located at the extracellular/membrane interface, facilitates the interaction with DPA that leads to inhibition of the receptor. Functional examinations of mutant receptors support the involvement of the M4 segment in the allosteric modulation of GABAρ1 by DPA.
authors: Neurobiology and Behavior, University of California, Irvine, California (A.L., J.M.R.R., R.M.); Psychiatry and Human Behavior, University of California, Irvine, California (A.L.); and The Queensland Brain Institute, St. Lucia, Queensland, Australia (A.E.-M.) alimonru@uci.edu.
authors: Agenor
authors: A
authors: Limon
authors: Neurobiology and Behavior, University of California, Irvine, California (A.L., J.M.R.R., R.M.); Psychiatry and Human Behavior, University of California, Irvine, California (A.L.); and The Queensland Brain Institute, St. Lucia, Queensland, Australia (A.E.-M.).
authors: Argel
authors: A
authors: Estrada-Mondragón
authors: Neurobiology and Behavior, University of California, Irvine, California (A.L., J.M.R.R., R.M.); Psychiatry and Human Behavior, University of California, Irvine, California (A.L.); and The Queensland Brain Institute, St. Lucia, Queensland, Australia (A.E.-M.).
authors: Jorge M Reyes
authors: JM
authors: Ruiz
authors: Neurobiology and Behavior, University of California, Irvine, California (A.L., J.M.R.R., R.M.); Psychiatry and Human Behavior, University of California, Irvine, California (A.L.); and The Queensland Brain Institute, St. Lucia, Queensland, Australia (A.E.-M.).
authors: Ricardo
authors: R
authors: Miledi
mesh_terms: D000818:Animals; D002417:Cattle; D003553:Cystine / Q000737:chemistry* / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D010851:Picrates / Q000378:metabolism* / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects / Q000502:physiology; D017433:Protein Structure, Secondary; D017434:Protein Structure, Tertiary / Q000187:drug effects / Q000502:physiology; D011963:Receptors, GABA-A / Q000737:chemistry* / Q000378:metabolism*; D014101:Torpedo; D014982:Xenopus laevis
chemical_list: D010851:Picrates; D011963:Receptors, GABA-A; C011454:dipicrylamine; D003553:Cystine